Anthony Bejjani1, Lindsay Burt2, Christina Washington3, Michael Terao4,5, Samir Housri6, Nadine Housri6,7. 1. Jonsson Comprehensive Cancer Center, Geffen School of Medicine at UCLA, Los Angeles, CA. 2. Department of Radiation Oncology, University of Utah Huntsman Cancer Hospital, Salt Lake City, UT. 3. Division of Gynecologic Oncology, Stephenson Cancer Center, University of Oklahoma Health Science Center, Oklahoma City, OK. 4. Division of Pediatric Oncology, St Jude Children's Research Hospital, Memphis, TN. 5. Division of Pediatric Hematology/Oncology, MedStar Georgetown University Hospital, Washington, DC. 6. theMednet.org, New York, NY. 7. Department of Radiation Oncology, Yale School of Medicine, Trumbull, CT.
Abstract
PURPOSE: COVID-19 is a rapidly emerging worldwide pandemic that has drastically changed health care across the United States. Oncology patients are especially vulnerable. Novel point-of-care resources may be useful to rapidly disseminate peer-reviewed information from oncology experts nationwide. We describe our initial experience with distributing this information through a private, curated, virtual collaboration question-and-answer (Q&A) platform for oncologists. METHODS: The Q&A database was queried for a 2-month period from March 12 to May 12, 2020. We collected the total number of views and unique viewers for the questions. We classified the questions according to their emphasis (practice management, clinical management, both) and disease type across radiation oncology, medical oncology, gynecologic oncology, and pediatric oncology. RESULTS: Seventy-nine questions were approved, 67 of which were answered and generated 49,494 views with 5,148 unique viewers. Most discussions covered clinical management, with breast cancer being the most active disease site. Ten questions covered pediatric oncology and gynecologic oncology. Forty-seven percent of the 11,010 users of the platform visited the website during the 2-month period. CONCLUSION: Discussions on the Q&A platform reached a substantial number of oncologists throughout the nation and may help oncologists to modify their treatment in real time with the rapidly evolving COVID-19 pandemic.
PURPOSE:COVID-19 is a rapidly emerging worldwide pandemic that has drastically changed health care across the United States. Oncology patients are especially vulnerable. Novel point-of-care resources may be useful to rapidly disseminate peer-reviewed information from oncology experts nationwide. We describe our initial experience with distributing this information through a private, curated, virtual collaboration question-and-answer (Q&A) platform for oncologists. METHODS: The Q&A database was queried for a 2-month period from March 12 to May 12, 2020. We collected the total number of views and unique viewers for the questions. We classified the questions according to their emphasis (practice management, clinical management, both) and disease type across radiation oncology, medical oncology, gynecologic oncology, and pediatric oncology. RESULTS: Seventy-nine questions were approved, 67 of which were answered and generated 49,494 views with 5,148 unique viewers. Most discussions covered clinical management, with breast cancer being the most active disease site. Ten questions covered pediatric oncology and gynecologic oncology. Forty-seven percent of the 11,010 users of the platform visited the website during the 2-month period. CONCLUSION: Discussions on the Q&A platform reached a substantial number of oncologists throughout the nation and may help oncologists to modify their treatment in real time with the rapidly evolving COVID-19 pandemic.
Authors: S B Soumerai; T J McLaughlin; J H Gurwitz; E Guadagnoli; P J Hauptman; C Borbas; N Morris; B McLaughlin; X Gao; D J Willison; R Asinger; F Gobel Journal: JAMA Date: 1998-05-06 Impact factor: 56.272
Authors: Eta S Berner; C Suzanne Baker; Ellen Funkhouser; Gustavo R Heudebert; Jeroan J Allison; Crayton A Fargason; Qing Li; Sharina D Person; Catarina I Kiefe Journal: Med Care Date: 2003-03 Impact factor: 2.983
Authors: Arjen Hoogendam; Anton F H Stalenhoef; Pieter F de Vries Robbé; A John P M Overbeke Journal: J Med Internet Res Date: 2008-10-03 Impact factor: 5.428
Authors: L Zhang; F Zhu; L Xie; C Wang; J Wang; R Chen; P Jia; H Q Guan; L Peng; Y Chen; P Peng; P Zhang; Q Chu; Q Shen; Y Wang; S Y Xu; J P Zhao; M Zhou Journal: Ann Oncol Date: 2020-03-26 Impact factor: 32.976
Authors: Y Helen Zhang; Elaine Cha; Kathleen Lynch; Renee Gennarelli; Jeffrey Brower; Michael V Sherer; Daniel W Golden; Susan Chimonas; Deborah Korenstein; Erin F Gillespie Journal: J Med Imaging Radiat Oncol Date: 2022-06-01 Impact factor: 1.667
Authors: Alise K Murray; Rose B McGee; Roya M Mostafavi; Xiaoqing Wang; Zhaohua Lu; Jessica M Valdez; Michael A Terao; Kim E Nichols Journal: Cancer Med Date: 2021-02-23 Impact factor: 4.452